Terence M. Williams MD, PhD

Articles by Terence M. Williams MD, PhD

Dr. Williams on NLR as a Prognostic Biomarker in NSCLC

May 4th 2020

Terence M. Williams, MD, PhD, discusses research examining a serum biomarker, neutrophil-to-lymphocyte ratio, in non–small cell lung cancer.

Parotid Node Metastases in Locally Advanced Nasopharyngeal and Oropharyngeal Cancer: Implications for Radiotherapy Target Volume Delineation

ByTerence M. Williams MD, PhD,Jeffrey M. Vainshtein, MD,Matthew E. Spector, MD,Douglas B. Chepeha, MD,Matthew Stenmark, MD,Avraham Eisbruch, MD

October 5th 2015

The ipsilateral parotidean nodes may be at risk of metastatic involvement when bulky ipsilateral level II metastases and multilevel nodal disease are co-existent, possibly due to retrograde lymphatic drainage.

Terence M. Williams MD, PhD

Articles by Terence M. Williams MD, PhD

Dr. Williams on NLR as a Prognostic Biomarker in NSCLC

Parotid Node Metastases in Locally Advanced Nasopharyngeal and Oropharyngeal Cancer: Implications for Radiotherapy Target Volume Delineation

Latest Updated Articles

Trending on OncLive

FDA Approves Pembrolizumab Plus Enfortumab Vedotin in MIBC

FDA Flashback: Breast Cancer Decisions and News From June 2026

Revisit Every OncLive On Air Episode From June 2026

Risvutatug Rezetecan Shows OS Benefit Over Topotecan in Relapsed SCLC

FDA Approves Subcutaneous Isatuximab Delivered Via On-Body Delivery System for Multiple Myeloma